Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;100(2):133-136.

Impact of Carotid atheroma on cardiovascular risk in Mauritanian hypertensive patients

Sirakhé Camara, Fatimata G Ba, Abderrahmane Hanne, Houleymata Ba, Horma Zein, Sana Ouali, Fatimata Barry, Ahmed Eba

Impact of Carotid atheroma on cardiovascular risk in Mauritanian hypertensive patients

Sirakhé Camara et al. Tunis Med. 2022.

Abstract

Aim: To determine the prevalence of carotid atheroma in hypertensive patients and assess the levels of cardiovascular risk.

Methods: This is a prospective study that took place in the outpatient department of the National Cardiology Center of Nouakchott over a period of 6 months (October 2019 to March 2020). Patients with hypertension without complications were included. Patients lost to followup and those whose records were incomplete were excluded from the study.

Results: Out of a total of 171 patients, a total of 93 patients (54.38%) was collected, of which 54.8% were women, 55.9% of the patients in the series were over 50 years old.The associated cardiovascular risk factors were dominated by dyslipidemia (27.9%), diabetes (20.4%), smoking (26.8%). hypertension was grade 2 in 47.3% of patients and grade 3 in 52.7% of patients. Left ventricular hypertrophy was noted in 77.4% of patients. Echo-Doppler of the supra-aortic trunks revealed atherosclerotic plaques in 63.4% of patients.

Conclusion: The prevalence of carotid atheroma in hypertensive patients at high cardiovascular risk level was frequent in our series, it follows from this to recommend early detection for optimal management.

PubMed Disclaimer

References

    1. Conroy R M, Pyorala K, Fitzgerald A P. European Heart Journal. 11. Vol. 24. Oxford University Press (OUP); 2003. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project; pp. 987–1003. - PubMed
    1. Assman G, Cullen P, Jossa F, Lewis B, Mancini M. Coronary heart disease: Reducing the risk. The scientific background to primary and secondary prevention of coronary heart disease. A world wilde view. International task force for the prevention of coronary heart disease. ArteriosclerThrombVascBiol. 1999;19:1819–1843. - PubMed
    1. Bryan W, Giuseppe M, Wilko S. ESC/ESH Guidelines for the management of arterial hypertension. EuropeanHeart Journal. 2018;00:1–98.
    1. Gosse P, Papaioannou G, Dubiez P, Reuter S, Lemetayer P. EMC - Cardiologie. 1. Vol. 3. Elsevier BV; 2008. Hypertrophie ventriculaire gauche au cours de l'hypertension artérielle; pp. 1–9.
    1. Barnett Henry J M, Taylor D Wayne, Eliasziw Michael, Fox Allan J, Ferguson Gary G, Haynes R Brian, Rankin Richard N, Clagett G Patrick, Hachinski Vladimir C, Sackett David L, Thorpe Kevin E, Meldrum Heather E, Spence J David. New England Journal of Medicine. 20. Vol. 339. Massachusetts Medical Society; 1998. Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis; pp. 1415–1425. - PubMed